Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing type 2 diabetes mellitus during a period of time
go back to main search page
Accession:CMO:0001137 term browser browse the term
Definition:The number of new cases of type 2 diabetes mellitus appearing in a study population during a specified period compared to the total number of individuals in the study population, expressed as a percentage. T2DM is a form of diabetes often, although not universally, associated with obesity, insulin resistance, hyperlipidemia(s) and cardiovascular symptoms such as hypertension.
Synonyms:related_synonym: NIDDM incidence;   T2D incidence;   T2DM incidence;   adult-onset diabetes mellitus incidence;   diabetes mellitus type II incidence;   non-insulin-dependent diabetes mellitus incidence;   type 2 diabetes mellitus incidence



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        diabetes mellitus incidence/prevalence measurement 3
          percentage of study population developing diabetes mellitus during a period of time 3
            percentage of study population developing type 2 diabetes mellitus during a period of time 0
paths to the root